What makes a good (and bad) pharmaceutical forecast model

Forecasting is essential in providing clarity on decision making about the future, but poor-quality forecasts can result in decisions which are commercially damaging to organisations.

Innovative Medicines Fund and the opportunity for ICSs to mo...

Making new product planning for life science more effective ...

The sooner a human-centred perspective is applied to the development of either a drug or device product, the more likely the product will be adopted and used because it’s been designed arou

Trying to get clarity on CDF and VPAS and implications for t...

Companies who are thinking about seeking funding via England’s new Innovative Medicines Fund (IMF) need to think through all the commercial implications, including whether spending in the I

What CVS’s Signify Health acquisition means for the future o...

CVS Health recently acquired home healthcare agency,

The criticality of compliance

Remaining compliant is imperative to the life sciences industry, so adhering to regulatory requirements is mandatory.